Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

NCT02770716 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatorenal Syndrome

Interventions

DRUG: Terlipressin
OTHER: Placebo

Sponsor

Mallinckrodt